Author Archive

COVID-19 Vaccines Should Be Labeled Gene Therapy Products

Written by Megan Redshaw

Now that the pandemic has ended, researchers are urging regulatory agencies to consider the safety issues associated with the rapid approval of COVID-19 vaccines—and to correctly classify messenger RNA (mRNA) vaccines as gene therapy products (GTPs) to prevent pharmaceutical companies from bypassing regulatory standards

Continue Reading 5 Comments

Fatal and Debilitating Smallpox Vaccine Induced Myocarditis

Written by Dr Peter McCullough MD, MPH

Over the course of the COVID-19 crisis we have heard from government officials and those supporting the mass vaccination campaign that the CDC Vaccine Adverse Event System (VAERS) is not reliable and that patient/family/healthcare provider reports into the system may not be accurate and thus cannot be used to assess causality

Continue Reading No Comments